UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$191M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$157M |
| 3 |
Pfizer
PFE
|
+$139M |
| 4 |
3M
MMM
|
+$131M |
| 5 |
Meta Platforms (Facebook)
META
|
+$106M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALTR
Altera Corp
ALTR
|
+$288M |
| 2 |
Intercontinental Exchange
ICE
|
+$247M |
| 3 |
RKT
ROCK-TENN COMPANY CL-A
RKT
|
+$142M |
| 4 |
Yelp
YELP
|
+$140M |
| 5 |
Salesforce
CRM
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.28% |
| 2 | Financials | 14.69% |
| 3 | Technology | 14.25% |
| 4 | Consumer Discretionary | 9.55% |
| 5 | Industrials | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
UTIW
1701
DELISTED
UTI WORLDWIDE INC
UTIW
| $854K | ﹤0.01% |
85,496
+9,300
| +12% | +$89.7K |
|
|
CCG
1702
DELISTED
CAMPUS CREST COMMUNITIES INC COM STK (MD)
CCG
| $853K | ﹤0.01% |
154,030
+14,300
| +10% | +$87.3K |
|
1703
First Citizens BancShares
FCNCA
$25.5B
| $851K | ﹤0.01% |
3,237
+77
| +2% | +$19.1K |
|
|
CMD
1704
DELISTED
Cantel Medical Corporation
CMD
| $851K | ﹤0.01% |
15,850
+1,500
| +10% | +$73K |
|
1705
KB Home
KBH
$3.49B
| $850K | ﹤0.01% |
51,198
+5,300
| +12% | +$80.9K |
|
1706
Pricesmart
PSMT
$5.5B
| $849K | ﹤0.01% |
9,300
+900
| +11% | +$75.4K |
|
1707
SAP
SAP
$230B
| $842K | ﹤0.01% |
11,985
-134
| -1% | -$9.94K |
|
1708
Interface
TILE
$2.04B
| $842K | ﹤0.01% |
33,598
+1,600
| +5% | +$35.4K |
|
|
FPO
1709
DELISTED
First Potomac Realty Trust
FPO
| $841K | ﹤0.01% |
81,603
+3,800
| +5% | +$41K |
|
|
CVSA
1710
Covista Inc
CVSA
$4.23B
| $840K | ﹤0.01% |
28,026
-7,404
| -21% | -$244K |
|
1711
Insight Enterprises
NSIT
$4.51B
| $840K | ﹤0.01% |
28,099
+1,100
| +4% | +$32.7K |
|
1712
Universal Corp
UVV
$1.27B
| $840K | ﹤0.01% |
14,654
+1,600
| +12% | +$80.9K |
|
1713
Trex
TREX
$4.93B
| $838K | ﹤0.01% |
67,824
+8,000
| +13% | +$103K |
|
|
MNTA
1714
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $837K | ﹤0.01% |
36,699
+13,100
| +56% | +$261K |
|
1715
Unifirst Corp
UNF
$5.22B
| $836K | ﹤0.01% |
7,470
+770
| +11% | +$89.5K |
|
|
KNGT
1716
DELISTED
KNIGHT TRANSPORTATION INC
KNGT
| $834K | ﹤0.01% |
31,179
+3,700
| +13% | +$99K |
|
1717
Worthington Enterprises
WOR
$2.83B
| $833K | ﹤0.01% |
44,926
+6,001
| +15% | +$102K |
|
1718
Korn Ferry
KFY
$4.2B
| $831K | ﹤0.01% |
23,898
+1,100
| +5% | +$36.3K |
|
|
IMGN
1719
DELISTED
Immunogen Inc
IMGN
| $830K | ﹤0.01% |
57,697
-1,300
| -2% | -$14.3K |
|
|
CBM
1720
DELISTED
Cambrex Corporation
CBM
| $830K | ﹤0.01% |
18,899
+800
| +4% | +$33.1K |
|
1721
New Oriental
EDU
$9.04B
| $829K | ﹤0.01% |
33,800
-3,000
| -8% | -$74.3K |
|
|
BKS
1722
DELISTED
Barnes & Noble
BKS
| $828K | ﹤0.01% |
48,690
+1,831
| +4% | +$28.6K |
|
|
ZSPH
1723
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
| $828K | ﹤0.01% |
+15,801
| New | +$778K |
|
|
MRH
1724
DELISTED
MONTPELIER RE HOLDINGS LTD
MRH
| $826K | ﹤0.01% |
20,921
+7,400
| +55% | +$289K |
|
|
CMO
1725
DELISTED
Capstead Mortgage Corp.
CMO
| $825K | ﹤0.01% |
74,396
+8,900
| +14% | +$105K |
|
Similar funds
UBS AM's Q2 2015 Portfolio in Review
As of Q2 2015, UBS AM held 2,771 positions worth $104B, up 0.68% from $104B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q2 2015 filing shows 148 new, 1,779 increased, 566 reduced and 77 closed positions. Its largest new stake was Viatris: 1,260,214 shares worth $85.5M. The largest sale was Altera Corp, an estimated $288M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Financials and Technology.
- UBS AM's largest Q2 2015 buy was Viatris: 1,260,214 shares worth $85.5M.
- UBS AM added most to Allergan plc in Q2 2015, an estimated $191M increase.
- UBS AM's biggest Q2 2015 reduction was Altera Corp, cutting an estimated $288M.
- UBS AM fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $78.3M.
- UBS AM's ten largest holdings make up 14% of its $104B portfolio in Q2 2015.
- UBS AM opened 148 new positions and closed 77 in Q2 2015.
- UBS AM's portfolio value rose 0.68% quarter-over-quarter to $104B.
Based on UBS AM's 13F filing for Q2 2015, filed 12 Aug 2015.